OSE Immunotherapeutics Reports Increased Shares and Cash in Liquidity Account
I'm PortAI, I can summarize articles.
OSE Immunotherapeutics reported that its liquidity account held 40,086 shares and €413,431.33 in cash as of December 31, 2025. From July 1 to December 31, 2025, there were 926 buy-side executions totaling 169,447 shares for €993,349.58 and 1,019 sell-side executions totaling 157,153 shares for €948,518.44. This is an increase from June 30, 2025, when the account had 27,792 shares and €454,733.83 in cash.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments